BCM
AERI

BCK Capital Management’s Aerie Pharmaceuticals AERI Stock Holding History

BCK Capital Management’s Portfolio AERI Stock Details AERI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-64,000
Closed -$968K – 101
2022
Q3 		$968K Buy
+64,000
New +$744K 0.7% 36

BCK Capital Management's AERI Position: Q4 2022 in Review

BCK Capital Management sold out of Aerie Pharmaceuticals (AERI) in Q4 2022, closing a stake of 64,000 shares — an estimated $968K sold.

BCK Capital Management first reported a position in AERI in Q3 2022 and held it in 1 quarter. The position peaked at $968K in Q3 2022. 0 funds tracked by Wall St. Rank hold AERI as of Q4 2022.

  • BCK Capital Management reported no remaining Aerie Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
  • BCK Capital Management sold 64,000 Aerie Pharmaceuticals shares in Q4 2022, an estimated $968K.
  • BCK Capital Management first reported a position in Aerie Pharmaceuticals in Q3 2022 and held it in 1 quarter.
  • BCK Capital Management's Aerie Pharmaceuticals position peaked at $968K in Q3 2022.
  • 0 funds tracked by Wall St. Rank held Aerie Pharmaceuticals as of Q4 2022.

Based on BCK Capital Management's 13F filing for Q4 2022, filed 9 Feb 2023.